Experimental and Molecular Medicine (Feb 2019)

Mechanism of the natural product moracin-O derived MO-460 and its targeting protein hnRNPA2B1 on HIF-1α inhibition

  • Nak-Kyun Soung,
  • Hye-Min Kim,
  • Yukihiro Asami,
  • Dong Hyun Kim,
  • Yangrae Cho,
  • Ravi Naik,
  • Yerin Jang,
  • Kusic Jang,
  • Ho Jin Han,
  • Srinivas Rao Ganipisetti,
  • Hyunjoo Cha-Molstad,
  • Joonsung Hwang,
  • Kyung Ho Lee,
  • Sung-Kyun Ko,
  • Jae-Hyuk Jang,
  • In-Ja Ryoo,
  • Yong Tae Kwon,
  • Kyung Sang Lee,
  • Hiroyuki Osada,
  • Kyeong Lee,
  • Bo Yeon Kim,
  • Jong Seog Ahn

DOI
https://doi.org/10.1038/s12276-018-0200-4
Journal volume & issue
Vol. 51, no. 2
pp. 1 – 14

Abstract

Read online

Cancer: How a plant metabolite analog suppresses tumor growth A synthetic analog of a chemical found in fruit suppresses tumor growth by targeting an RNA-binding protein (hnRNPA2B1) and preventing the production of a pro-cancer regulatory factor. Nak-Kyun Soung from the Korea Research Institute of Bioscience and Biotechnology, Cheongju, South Korea, and coworkers built on their previous discovery that a compound derived from a medicinal plant metabolite can suppress the activity of hypoxia-inducible factor-1α (HIF-1α). This protein, which is involved in many aspects of cancer biology, is activated in the low-oxygen microenvironments found inside tumors. The researchers show that the compound binds to a protein that helps with the conversion of HIF-1α–encoding RNA transcripts into HIF-1α proteins. Liver cancer cells treated with the compound grew slowly and produced less HIF-1α under both normal and low-oxygen culture conditions, highlighting the potential of this anti-cancer strategy.